Host Genetic Variants, Epstein-Barr Virus Subtypes, and the Risk of Nasopharyngeal Carcinoma: Assessment of Interaction and Mediation
Miao Xu,Ruimei Feng,Zhonghua Liu,Xiang Zhou,Yanhong Chen,Yulu Cao,Linda Valeri,Zilin Li,Zhiwei Liu,Su-Mei Cao,Qing Liu,Shang -Hang Xie,Ellen T. Chang,Wei-Hua Jia,Jincheng Shen,Youyuan Yao,Yong -Lin Cai,Yuming Zheng,Zhe Zhang,Guangwu Huang,Ingemar Ernberg,Minzhong Tang,Weimin Ye,Hans-Olov Adami,Yi-Xin Zeng,Xihong Lin
DOI: https://doi.org/10.1016/j.xgen.2023.100474
2024-01-01
Cell Genomics
Abstract:Epstein-Barr virus (EBV) and human leukocyte antigen (HLA) polymorphisms are well-known risk factors for nasopharyngeal carcinoma (NPC). However, the combined effects between HLA and EBV on the risk of NPC are unknown. We applied a causal inference framework to disentangle interaction and mediation effects between two host HLA SNPs, rs2860580 and rs2894207, and EBV variant 163364 with a population-based case-control study in NPC-endemic southern China. We discovered the strong interaction effects between the high-risk EBV subtype and both HLA SNPs on NPC risk (rs2860580, relative excess risk due to interaction [RERI] = 4.08, 95% confidence interval [CI] = 2.03-6.14; rs2894207, RERI = 3.37, 95% CI = 1.59-5.15), accounting for the majority of genetic risk effects. These results indicate that HLA genes and the high-risk EBV have joint effects on NPC risk. Prevention strategies targeting the high-risk EBV subtype would largely reduce NPC risk associated with EBV and host genetic susceptibility.